FDA admits Invermectin can be used to treat COVID
- Thread starter AC2020
- Start date
Name a better control phrase than “conspiracy theory.”
It’s like magic.
It’s like magic.
Gullible af
www.verifythis.com
carry on
No, the FDA did not approve the use of ivermectin to treat COVID-19
An interview on Fox Business Network sparked speculation that the FDA “quietly approved” ivermectin as treatment for COVID-19. That’s false.
www.verifythis.com
carry on
I love legaleeze. This is the same legal standing that allows most puberty blockers to be used today (as an off-label use). Weird that the FDA never speaks up about that not being recommended, yet screamed loudly from the rooftops against anyone who recommended Ivermectin.Gullible af
No, the FDA did not approve the use of ivermectin to treat COVID-19
An interview on Fox Business Network sparked speculation that the FDA “quietly approved” ivermectin as treatment for COVID-19. That’s false.
carry on
Study supports evidence ivermectin is ineffective at treating COVID-19
PLATCOV, a platform to assess the effectiveness of drugs against COVID-19, suggests that ivermectin has no significant antiviral activity against SARS-CoV-2.
elifesciences.org
How many boosters now?Gullible af
No, the FDA did not approve the use of ivermectin to treat COVID-19
An interview on Fox Business Network sparked speculation that the FDA “quietly approved” ivermectin as treatment for COVID-19. That’s false.
carry on
Interesting study. Couple of questions from the cynic in the room:Study supports evidence ivermectin is ineffective at treating COVID-19
PLATCOV, a platform to assess the effectiveness of drugs against COVID-19, suggests that ivermectin has no significant antiviral activity against SARS-CoV-2.
1) How come they can't come out and say how it did against the 'no drugs' solution which was part of their sample? They quote that it was 9% slower at reducing viral load than the 'other drugs' category. But that's not the same as saying it is ineffective as a treatment.
2) What does the study mean by 'estimated' viral load. Are we 'tweaking' the measurements based on an expected outcome? When I see terms like this combined with such minute sample sizes, I can't help but wonder how much of the data is 'adjusted or weighted (to use the scientific term)' based on expected results.
Retired on a beach, probably in a non-extradition country, with his millions doled out from his pharma brothers and Moderna stock options.
That was a summary. The answers to your questions are in the actual article. Link below.
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)
Pharmacometric evaluation of viral clearance rates based on frequent oropharyngeal sampling is a highly efficient and well-tolerated method of assessing and comparing SARS-CoV-2 antiviral therapeutics in vivo.
elifesciences.org
